Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VivosRDGL -3.38% Days Inventory is 118.21 as of Mar. 2026, which is 27% below its 10-year median of 162.54. The stock has 4 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Vivos ranks better than 66.33% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Vivos's Average Total Inventories for the
three
months ended in Mar. 2026 was $0.06 Mil. Vivos's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $0.04 Mil.
Hence, Vivos's Days Inventory for the
three
months ended in Mar. 2026 was 118.21.
The historical rank and industry rank for Vivos's Days Inventory or its related term are showing as below:
RDGL'
s Days Inventory Range Over the Past 10 Years
Min: 139.07 Med: 162.54 Max: 162.54
Current: 139.07
During the past 13 years, Vivos's highest Days Inventory was 162.54. The lowest was 139.07. And the median was 162.54.
RDGL's Days Inventory is ranked better than 66.33% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.47
vs RDGL: 139.07
Vivos's Days Inventory
increased
from Mar. 2025 (53.23) to Mar. 2026 (118.21).
It might indicate that Vivos's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vivos's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.77.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vivos's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.58.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vivos's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vivos's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vivos Days Inventory Related Terms
Vivos Days Inventory Historical Data
* Premium members only.
The historical data trend for Vivos's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RDGL vs ARAY, FOFA, TELA: Days Inventory Comparison
For the Medical Devices subindustry, Vivos's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vivos Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vivos's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vivos's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivos (RDGL) has a Days Inventory of 118.21 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vivos and its competitors. This is 27% below median its historical median of 162.54. Over the past decade, Vivos' Days Inventory has ranged from 139.07 to 162.54. According to the industry distribution chart, Vivos ranks #265 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 33.7%.
Is Vivos' Days Inventory too high?
Vivos' current Days Inventory of 118.21 is 27% below median its 10-year median of 162.54. Over the past 10 years, this metric has ranged from a low of 139.07 to a high of 162.54. The Medical Devices & Instruments industry median Days Inventory is 179.47. Vivos' value of 118.21 is 34.1% below this industry median. Based on the distribution chart, Vivos ranks #265 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Vivos' Days Inventory compare to ARAY and FOFA?
According to the Medical Devices & Instruments industry distribution chart, Vivos ranks #265 out of 787 companies for Days Inventory. This puts Vivos in the upper half of its industry. The industry median Days Inventory is 179.47. Vivos' value of 118.21 is 34.1% below this benchmark. Historically, Vivos' own Days Inventory has ranged from 139.07 to 162.54 over the past decade. While the company's 10-year median is 162.54 vs. the industry median of 179.47, Vivos has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.47, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vivos's current Days Inventory of 118.21 is 34.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vivos and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vivos's current Days Inventory is 118.21, which is 27% below median its own 10-year median of 162.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivos stock overvalued right now?
Vivos (RDGL) has a current Days Inventory of 118.21. The current Days Inventory is 118.21, which is 27% below median its 10-year median of 162.54 and 34.1% below the Medical Devices & Instruments industry median of 179.47. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vivos (RDGL), the current Days Inventory is 118.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vivos Inc is a radiation oncology medical device company engaged in the development of its yttrium-90 (Y-90) based precision radionuclide therapy devices. Its portfolio includes RadioGel Precision Radionuclide Therapy (Human Division) for treating solid tumors and positive surgical margins in humans and IsoPet (Animal Division) for treating solid tumors in animals. Vivos also sells PLGA-g-PEG polymers and PrecisionGel, a hydrogel polymer platform for delivering active pharmaceutical ingredients and therapeutic agents. The company currently mainly operates in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RDGL has been successfully added to your 
